Croteau, David https://orcid.org/0000-0002-5561-6940
Pinnow, Ellen
Wu, Eileen
Muñoz, Monica
Bulatao, Ilynn
Dal Pan, Gerald
Article History
Accepted: 15 December 2021
First Online: 3 February 2022
Declarations
:
: No sources of funding were used to conduct this study or prepare this manuscript.
: David Croteau, Ellen Pinnow, Eileen Wu, Monica Muñoz, Ilynn Bulatao, and Gerald Dal Pan have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: In addition to the data found on the public FDA websites referred to in this article, the analytic data sets, redacted for drug manufacturer proprietary information, can be made available upon request to the corresponding author.
: Not applicable.
: The authors contributed sufficiently to the manuscript, with individual contributions as follows: concept and planning of the work described (DC, EP, EW, MM, IB, GDP); acquisition (EP), analysis (DC, EP, EW, MM, IB), and interpretation of the data (DC, EP, EW, MM, IB, GDP); drafting and/or critical revision of the manuscript (DC); and approval of the final submitted version of the manuscript (DC, EP, EW, MM, IB, GDP). Therefore, all authors share collective responsibility and accountability for the manuscript.